Satellite Symposia

Programme Details:

Satellite Symposium – Pfizer

Session Title:
Accelerating the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM): the role of nuclear scintigraphy and other imaging tools

Session Summary:
This Satellite Symposium will discuss the important roles of nuclear scintigraphy and cardiac imaging in the early diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM), through exploration of clinical ‘red flags’, non-invasive nuclear imaging techniques, and the value and benefit of adequate patient management.

Chairperson:
TBC

Programme:

• 13:15–13:30 – Cardiac amyloidosis and the role of nuclear medicine
  • TBC
• 13:30–13:40 – Red flags: the importance of constant vigilance
  • TBC
• 13:40–13:50 – Long-term management of ATTR-CM
  • TBC
• 13:50–14:05 – Non-invasive tools for the diagnosis and monitoring of ATTR-CM
  • TBC
• 14:05–14:15 – Panel discussion and Q&A
  • TBC – All faculty

Programme Details:

Satellite Symposium – Telix Pharmaceuticals

Session Title:
Shifting Perspectives in Genitourinary Oncology through Nuclear Medicine

Chairperson:
Matthias Eiber, MD, PhD, Department of Nuclear Medicine, Technische Universität München, Munich, Germany

Programme:

• PSMA-ligand PET imaging: Current status and impact on patient management (15 min presentation, 5 min discussion)
  • Professor Matthias Eiber – Department of Nuclear Medicine, Technische Universität München, Munich, Germany
• Interventional nuclear medicine: focus on radioguided surgery in urology cancers (15 min presentation, 5 min discussion)
  • Professor Jochen Walz – Unit Chief, Institut Paoli Calmette, Marseille, France
• Redefining the management of Renal Cancer patients (15 min presentation, 5 min discussion)
  • Doctor Stijn Muselaers – Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands
• Establishing radio ligand imaging and therapy in hospital practice (15 min presentation, 5 min discussion)
  • Professor Zéna Wimana – Radiopharmacy Manager, Department of Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium

Programme Details:

Satellite Symposium – Boston Scientific International SA

Session Title:
Y-90 Glass Microspheres: Personalized Dosimetry, Guidelines and Clinical Data

Chairperson:
Ken Herrmann

Speakers:
Etienne Garin, Marnix Lam and Manuel Weber

Programme:
Focus on personalized dosimetry and Simplicit90YTM Software, while discussing the TARGET study, with case examples, and an overview of radioembolization of HCC in the EANM Guidelines.

Programme Details:

Will follow here soon.

Programme Details:

Satellite Symposium – OncoBeta GmbH

Session Title:
Rhenium-SCT the future of treating Non-Melanoma skin cancer – A new liaison between Nuclear medicine and Dermatology

Speaker:
Dr. Martin Heuschkel (Department of Nuclear Medicine, University Clinic Rostock)
Dr. Jens Kurth (Department of Nuclear Medicine, University Clinic Rostock)
Prof. Julia Tietze (Department of Dermatology, University Clinic Rostock)

Programme:

• Non-Melanoma skin cancer and the potential of using Re188 for treatment
• Resent Study Results from the Rhenium-SCT Rostock Trial
• Practical Demonstration
• Radiation protection in case of high energy beta emitter Re188

Programme Details:

Will follow soon

Programme Details:

Satellite Symposium – Advanced Accelerator Applications International

Session Title: PSMA-targeted Theranostics: Towards Clinical Implementation in Advanced Prostate Cancer

Programme Details:

Satellite Symposium – GE Healthcare

Session Title:
How to make Molecular Imaging more Personalised?

Chairperson:
Ben Newton PhD, General Manager Oncology at GE Healthcare

Programme:

• Investing in Next Generation Radiotracers to Improve Patient Outcomes
  • Paul Evans PhD, Head of Global R&D at GE Healthcare
• Introducing New Digital PET/CT Platform
  • Prof. Frédéric Courbon, IUCT Oncopole, Toulouse, France
• Unlocking the Potential of Theranostics with StarGuide^TM
  • Prof. Patrick Flamen, Jules Bordet Institute, Brussels, Belgium
• Brain Motion Management with SIGNA^TM PET/MR
  • Matthew Spangler-Bickell PhD, PET/MR Systems Engineer at GE Healthcare

Programme Details:

Satellite Symposium – Blue Earth Diagnostics Ltd

Session Title:
What, How and Why of Cardiac PET

Chairperson:
Dr. Tahir Saleem Sheikh
Medical Director – EU & UK Medical Affairs, Blue Earth Diagnostics Ltd

Programme:

• What are the fundamentals of Cardiac PET, and how do we improve patient access in Europe?

Speaker: Dr Hein Verberne MD PhD
Department of Radiology & Nuclear Medicine,
University of Amsterdam, The Netherlands

• How to establish your Cardiac PET service

Speaker: Jessica Williams MS CNMT
Cardiology Application Specialist,
Blue Earth Diagnostics Ltd

• Why perform Cardiac PET – understanding the clinical value

Speaker: Dr Parthiban Arumugam MD
Clinical Director Nuclear Medicine,
Manchester University NHS FT, Manchester, UK

Programme Details:

Will follow soon

Programme Details:

Satellite Symposium – Terumo Europe Interventional Systems

Session Title:
Advancing SIRT dosimetry with The Holmium Platform

Chairperson:
Prof Dr. C. Deroose

Programme:

• Introducing the EANM SIRT dosimetry guidelines & products
• Recent clinical evidence & dosimetry guidance of Holmium-166 SIRT
• How is individualized SIRT treatment performed in routine clinical practice?
• The Clinical Program of the Holmium Platform

Speaker:

Prof. Dr. C. Deroose , UZ Leuven, BelgiumDr. P. De Bondt , OLV Aalst, Belgium
Dr I. Insausti Gorbea, Hospital Universitario de Navarra, Spain
Prof. Dr. M. Lam, UMC Utrecht, Netherlands
Dr. R. Sciuto, Regina Elena National Cancer Institute, Rome, Italy

Programme Details:

Satellite Symposium – Eckert & Ziegler, PentixaPharm

Session Title:
Theranostic Innovations in Solid and Non-Solid Tumors Targeting CXCR4, HER2, FAP, αvβ6 & more

Chairperson:
Prof. Margret Schottelius (PhD) | Associate Professor, Translational Radiopharmaceutical Sciences, CHUV | Lausanne University Hospital

Programme:

• A Theranostic Roadmap: The Long or the Short Way from Diagnostics to Therapeutics
  • Margret Schottelius (PhD) | Associate Professor, Translational Radiopharmaceutical Sciences, CHUV | Lausanne University Hospital
• CXCR4 Based Theranostic: Imaging and Clinical Implications in MZL and other Hematological Neoplasms
  • Andreas Buck (MD) | Clinical Director Nuclear Medicine, University Hospital Würzburg
• CXCR4 Based Theranostic: A Promising Approach for Accurate Imaging of Multiple Myeloma and Therapy of Leukemia
  • Françoise Kraeber-Bodéré (PhD, MD) | Head of Nuclear Medicine Department, CHU Nantes
• Radiolabeled Single-Domain Antibodies as Theranostic Tools in Oncology
  • Matthias D’Huyvetter (PhD) | Science Director, Precirix NV | Research Professor, Vrije Universiteit Brussel
• Ga-68-Trivehexin for PET-Imaging of Carcinomas: The Way To Clinics
  • Johannes Notni (PhD) | Co-Founder and CSO, TRIMT GmbH
  • Jakub Simecek (PhD) | Co-Founder and CEO, TRIMT GmbH

Programme Details:

Satellite Symposium – Curium

Session Title:
Innovations in Prostate Cancer Imaging and Therapy

Chairperson:
Sakir Mutevelic, Chief Medical Officer at Curium

Programme:

• Christoph Rischpler, University Hospital Essen, Department of Nuclear Medicine, Germany
  • Professor of Nuclear Medicine
  • Results from the Python trial: A Prospective Study on [¹⁸F]DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
• Andrei Iagaru, University of Stanford, Department of Nuclear Medicine and Molecular Imaging, USA
  • Professor of Radiology & Nuclear Medicine
  • One year and 500 patients later: Pylarify® ([¹⁸F]DCFPyL) in the daily clinical practice
• Aseem Anand, EXINI Diagnostics AB, Sweden
  • Vice President
  • Artificial Intelligence for Enhanced Clinical Utility of Molecular Imaging
• Harshad R. Kulkarni, Zentralklinik Bad Berka, Department of Nuclear Medicine, Germany
  • Consultant Nuclear Medicine
  • Chief Medical Advisor, BAMF Health, Grand Rapids, USA
  • PSMA-targeted Radioligand Therapy with [¹⁷⁷Lu]Lu-PSMA-I&T: A Decade of Experience

Programme Details:

Will follow soon